Veeva Systems Inc. (NYSE:VEEV) is one of the best healthcare AI stocks to buy now. On December 15, Stifel reiterated a Buy rating on Veeva Systems Inc. (NYSE:VEEV), even as some big pharmaceutical customers shift away from its legacy CRM platform. Stifel sees these migrations as a small, manageable issue that won’t derail Veeva’s overall momentum. Stifel Maintains Buy on Veeva (VEEV) Despite CRM Customer Migrations According to the analyst’s assessment, Veeva currently serves 18 of the top 20 pharmaceuti ...